Clozapine Tablet
Product Images NDC 0904-7087

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clozapine (NDC 0904-7087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (9db7aefb F607 4158 A310 181e631bc648 00)

CLOZAPINE 200 mg oral tablets by Major Pharmaceuticals, unit dose packaging containing 100 tablets. The label includes the NDC number 0904-7088-61 and states Rx only. Storage instructions, distributor information, and a barcode are also visible on the label.*

FDA Label Image

Carton Label (9db7aefb F607 4158 A310 181e631bc648 01)

Label of CLOZAPINE tablets USP 100 mg oral tablets by Major Pharmaceuticals. The unit dose package contains 100 tablets with NDC 0904-7087-61. The label includes prescribing warnings, storage instructions (20° to 25°C), and notes that the product is for Rx only and not for institutional use. Distributed by Major Pharmaceuticals in Livonia, MI.*

FDA Label Image

Carton Label (9db7aefb F607 4158 A310 181e631bc648 02)

Packaging label for Major Pharmaceuticals CLOZAPINE tablets USP 25 mg oral tablets in a unit dose format. The label indicates 100 tablets per package with NDC 0904-7089-61, prescription only. Directions include storage at 20° to 25°C, keeping out of reach of children, and contigent upon ANC results for dispensing. Manufacturer and distributor details are also present.*

FDA Label Image

Figure 1. Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Clozapine Fig1)

A line graph titled 'Cumulative Probability of a Significant Suicide Attempt or Hospitalization to Prevent Suicide in Patients with Schizophrenia or Schizoaffective Disorder at High Risk of Suicidality.' The x-axis represents time in months (0 to 24), and the y-axis represents cumulative probability (0 to 0.5). Two lines compare Clozapine and Olanzapine over time, showing a cumulative probability of 24% for Clozapine and 32% for Olanzapine at 24 months.*

FDA Label Image

Chemical Structure (Clozapine Str)

Chemical structure of clozapine showing its molecular components and rings, with a molecular weight of 326.83.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.